Pyridine-appended Bis-functionalized 1,2,3 Triazoles as Inhibitors of Protein Tyrosine Phosphatases

Faculty Mentor

Shainaz Landge

Location

Russell Union Ballroom

Type of Research

On-going

Session Format

Poster Presentation

College

College of Science & Mathematics

Department

Biochemistry, Chemistry, and Physics

Abstract

Protein Tyrosine Phosphatases (PTP) play a critical role in bacteria’s ability to infect a host. Consequently, PTP inhibitors have recently been investigated for their antibacterial ability. A series of novel 1,2,3-triazole derivatives were synthesized via copper-catalyzed azide-alkyne cycloaddition (CuAAC) and were characterized using nuclear magnetic resonance (NMR) spectroscopy, infrared (IR) spectroscopy, melting point analysis, and high-resolution mass spectrometry (HRMS). In silico molecular docking studies were conducted to predict binding affinities and interaction profiles of the compounds with the protein tyrosine phosphatase target. Subsequent in vitro enzyme inhibition assays were performed to assess biological activity and validate computational predictions. These characterizations provided a prediction for the pharmacokinetics of the synthesized compounds, including binding and drug bioavailability in a biological environment. This goal of this research is to find a compound capable of inhibiting protein tyrosine phosphatase (PTP) activity. This is significant because (PTP) activity is vital for bacterial function and pathogenicity. If we are successful, we will have synthesized a compound that can kill bacteria by inhibiting their ability to successfully infect a host.

Program Description

.

Start Date

4-23-2026 2:00 PM

End Date

4-23-2026 4:00 PM

This document is currently not available here.

Share

COinS
 
Apr 23rd, 2:00 PM Apr 23rd, 4:00 PM

Pyridine-appended Bis-functionalized 1,2,3 Triazoles as Inhibitors of Protein Tyrosine Phosphatases

Russell Union Ballroom

Protein Tyrosine Phosphatases (PTP) play a critical role in bacteria’s ability to infect a host. Consequently, PTP inhibitors have recently been investigated for their antibacterial ability. A series of novel 1,2,3-triazole derivatives were synthesized via copper-catalyzed azide-alkyne cycloaddition (CuAAC) and were characterized using nuclear magnetic resonance (NMR) spectroscopy, infrared (IR) spectroscopy, melting point analysis, and high-resolution mass spectrometry (HRMS). In silico molecular docking studies were conducted to predict binding affinities and interaction profiles of the compounds with the protein tyrosine phosphatase target. Subsequent in vitro enzyme inhibition assays were performed to assess biological activity and validate computational predictions. These characterizations provided a prediction for the pharmacokinetics of the synthesized compounds, including binding and drug bioavailability in a biological environment. This goal of this research is to find a compound capable of inhibiting protein tyrosine phosphatase (PTP) activity. This is significant because (PTP) activity is vital for bacterial function and pathogenicity. If we are successful, we will have synthesized a compound that can kill bacteria by inhibiting their ability to successfully infect a host.